Ignite Creation Date:
2024-05-06 @ 1:11 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03952325
Status:
TERMINATED
Last Update Posted:
2021-07-30
First Post:
2019-05-14
Brief Title:
Tesetaxel Plus 3 Different PD-L1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC
Sponsor:
Odonate Therapeutics Inc
Organization:
Odonate Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-14
First Submit QC Date:
May 14 2019
Study First Post Date:
2019-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-26
Last Update Post Date:
2021-07-30
Last Update Post Date Type:
ACTUAL